Effects of selective tachykinin-receptor antagonists on tachykinin- induced airway mucus secretion in the rat

Neuropeptides

Volumn 33, Issue 1, 1999, Pages 55-61

  Wagner, U ^a   Fehmann, H C ^a   Bredenbroker D ^a   Klube D ^a   Lange, A ^a   Von Wichert, P ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROKININ A; NEUROKININ B; NOLPITANTIUM; OSANETANT; SAREDUTANT; SUBSTANCE P; TACHYKININ RECEPTOR ANTAGONIST;

ANIMAL CELL; ARTICLE; BREATHING MUSCLE; CHOLINERGIC NERVE; DRUG EFFECT; DRUG POTENCY; MUCUS SECRETION; NERVE CELL NETWORK; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; TRACHEA MUCOSA;

ANIMALIA;

EID: 0033083581     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.1999.0014     Document Type: Article

References (39)

1. Wagner U, Fehmann H-C, Bredenbröker D et al. Amylin stimulates airway secretion in the rat. Res Exp Med 1993; 193: 347-352.
2. Piedimonte G. Tachykinin petides, receptors, and peptidases in airway disease. Experimental Lung Research 1995; 21: 809-834.
3. Baraniuk JN, Kaliner MA. Neuropeptides in the upper and lower respiratory tract. Immunology and Allergy Clinics of North America 1990; 10: 383-407.
4. Casale TB. Neuropeptides and the lung. J Allergy Clin Immunol 1991; 88: 1-16.
5. Coles SJ, Neill KH, Reid LM. Potent stimulation of glycoprotein secretion in canine trachea by substance P. J Appl Physiol 1984; 57: 1323-1327.
6. Rogers DF, Aursudkij B, Barnes PJ. Effects of TK's on mucus secretion in human bronchi in vitro. Eur J Pharmacol 1989; 174:283-286.
7. Gentry S Tachykinin receptors mediating airway macromolecular secretion. Life Sciences 1991; 48: 1609-1618.
8. Wagner U, Fehmann B, Bredenbröker D et al. Galanin and somatostatin inhibition of substance P-induced airway mucus secretion in the rat. Neuropeptides 1995; 28: 59-64.
9. Wagner U, Fehmann B, Bredenbröker D, Yu F, Earth PJ, von Wichert P. Galanin and somatostatin inhibition of neurokinin A and B induced airway mucus secretion in the rat. Life Sciences 1995; 57: 283-289.
10. Guard S, Watson SP. Tachykinin receptor types: Classification and membrane signalling mechanisms. Neurochem Int 1991; 18: 149-165.
11. Maggi CA. The mammalian tachykinin receptors. Gen Pharmac 1995; 26: 911-944.
12. Borson DB, Gashi AA, Nadel JA. Methods for studying secretions from airways. In: Methods in Bronchial Mucology. Braga, PC, Allegra, L. eds 1st ed. New York: Raven Press. 1988: 303.
13. 2. Eur Respir J 1993; 6 (Suppl. 17): 473s.
14. Wagner U, von Wiehert P. Control of mucus secretion in airways. Respiration 1991; 58: 1-8.
15. 2 receptors in the circular muscle of the guinea pig ileum and proximal colon. Br J Pharmacol 1994; 112: 150-160.
16. 1 tachykinin receptor: Characterization on the U373MG cell line. J Neurochem 1994; 62: 1399-1407.
17. Meini S, Mak JC, Rohde JA, Rogers DF. Tachykinin control of ferret airways: Mucus secretion, bronchoconstriction and receptor mapping. Neuropeptides 1993; 24: 81-89.
18. 1 receptors. Neuropharmacology 1994; 33: 167-179.
19. 1 receptor antagonist. Eur J Pharmacol 1993; 250: 403-413.
20. 2 receptor subtypes in the rat. Eur J Pharmacol 1998; 352: 103-109.
21. 2 receptor antagonist, in guinea pig. Eur J Pharmacol 1998; 352: 279-288.
22. 2) receptors. Am Rev Respir Dis 1992; 146: 1177-1181.
23. Advenier C, Rouissi N, Nguyen QT et al. Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist. Biochem Biophys Res Commun 1992; 184: 1418-1424.
24. 2 receptor antagonist. Eur J Pharmacol 1993; 234: 83-90.
25. 3 receptors in rabbit isolated iris sphincter muscle. Br J Pharmacol 1997; 120: 93-101.
26. Chung FZ, Wu LH, Tian Y et al. Two classes of structurally different antagonists display similar species preference for the human tachykinin neurokinin3 receptor. Mol Pharmacol 1995; 48: 711-716.
27. 3 receptor. Pharmacology 1996; 52: 283-291.
28. 3 receptor expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 1995; 274: 148-154.
29. Patacchini R, Bartho L, Holzer P, Maggi CA. Activity of SR 142801 at peripheral tachykinin receptors. Eur J Pharmacol 1995; 278: 17-25.
30. 3 receptor antagonist SR 142801. Eur J Pharmacol 1997; 319: 307-316.
31. Barnes PJ. Allergic inflammatory mediators an bronchial hyperresponsiveness. Immunology and Allergy Clinics of North America 1990; 10, 241-249.
32. Gerard NP, Bao L, Ping HX, Gerard C. Molecular aspects of the tachykinin receptors. Regul Pept 1993; 43, 21-35.
33. Advenier C, Lagente V, Boichot E. The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough. Eur Respir J 1997; 10: 1892-1906.
34. 2 receptors in substance P-induced microvascular leakage, hypersensitivity and airway hyperresponsiveness in guinea-pigs. Eur Respir J 1996; 9: 1445-1450.
35. Quian Y, Emonds-Alt X, Advenier C. Effects of capsaicin, (±)-CP-96,345 and SR 48968 on the bradykinin-induced airways microvascular leakage. Pulm Pharmacol 1993; 6: 63-67.
36. 2 receptor antagonist. Eur J Pharmacol 1993; 250: 169-171.
37. Girard V, Naline E, Vilain P, Emonds-Alt X, Advenier C. Effect of the two tachykinin antagonists, SR 48968 and SR 140333, on cough induced by citric acid in the unanaesthesized guinea-pig. Eur Respir J 1995; 8: 1110-1114.
38. Braunstein G, Fajac I, Lacronique J, Frossard N. Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis. Am Rev Respir Dis 1991; 144: 630-635.
39. 3 receptor antagonist, SR 142801, of substance P-induced microvascular leakage hypersensitivity and airway hyperresponsiveness in guineapigs. Am J Respir Crit Care Med 1996; 153: A163.